122 related articles for article (PubMed ID: 6151597)
1. Determination of orally coadministered nadolol and its deuterated analogue in human serum and urine by gas chromatography with selected-ion monitoring mass spectrometry.
Cohen AI; Devlin RG; Ivashkiv E; Funke PT; McCormick T
J Pharm Sci; 1984 Nov; 73(11):1571-5. PubMed ID: 6151597
[TBL] [Abstract][Full Text] [Related]
2. Fluorometric determination of nadolol in human serum and urine.
Ivashkiv E
J Pharm Sci; 1977 Aug; 66(8):1168-72. PubMed ID: 19616
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of tertatolol in biological fluids by gas chromatography-mass spectrometry.
Staveris S; Blaise P; Efthymiopoulos C; Schneider M; Jamet G; Jung L; Koffel JC
J Chromatogr; 1985 Apr; 339(1):97-103. PubMed ID: 2862155
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantitative determination of tertatolol and its hydroxylated metabolite in human plasma and urine by gas chromatography-mass spectrometry.
Efthymiopoulos C; Staveris S; Weber F; Koffel JC; Jung L
J Chromatogr; 1987 Oct; 421(2):360-6. PubMed ID: 2892852
[No Abstract] [Full Text] [Related]
5. Determination of serum nadolol levels by GLC--selected ion monitoring mass spectrometry: comparison with a spectrofluorometric method.
Funke PT; Malley MF; Ivashkiv E; Cohen AI
J Pharm Sci; 1978 May; 67(5):653-7. PubMed ID: 25332
[TBL] [Abstract][Full Text] [Related]
6. Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent.
Bianchetti G; Ganansia J; Morselli PL
J Chromatogr; 1979 Aug; 176(1):134-9. PubMed ID: 44712
[No Abstract] [Full Text] [Related]
7. Elucidation of the structure of talinolol metabolites in man. Determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum.
Oertel R; Richter K; Trausch B; Berndt A; Gramatté T; Kirch W
J Chromatogr B Biomed Appl; 1994 Oct; 660(2):353-63. PubMed ID: 7866526
[TBL] [Abstract][Full Text] [Related]
8. Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. IV. Nadolol diastereomers: demonstration of pharmacokinetic and binding equivalence.
Piotrovskii VK; Zhirkov YuA ; Metelitsa VI
J Chromatogr; 1984 Aug; 309(2):421-5. PubMed ID: 6148352
[No Abstract] [Full Text] [Related]
9. Quantitative determination of dexamethasone in human plasma by stable isotope dilution mass spectrometry.
Kasuya Y; Althaus JR; Freeman JP; Mitchum RK; Skelly JP
J Pharm Sci; 1984 Apr; 73(4):446-51. PubMed ID: 6726626
[TBL] [Abstract][Full Text] [Related]
10. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs.
Patel BR; Kirschbaum JJ; Poet RB
J Pharm Sci; 1981 Mar; 70(3):336-8. PubMed ID: 6115047
[TBL] [Abstract][Full Text] [Related]
11. Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.
Poirier JM; Perez M; Cheymol G; Jaillon P
J Chromatogr; 1988 Apr; 426(2):431-7. PubMed ID: 2899087
[No Abstract] [Full Text] [Related]
12. Simultaneous determination of carvedilol and ampicillin sodium by first-derivative fluorometry in the presence of human serum albumin.
Wang HY; Xiao Y; Han J
Anal Sci; 2005 May; 21(5):537-40. PubMed ID: 15913143
[TBL] [Abstract][Full Text] [Related]
13. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
Bühring KU; Garbe A
J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
[TBL] [Abstract][Full Text] [Related]
14. Determination of betaxolol, a new beta-blocker, by gas chromatography mass spectrometry: application to pharmacokinetic studies.
Hermann P; Fraisse J; Allen J; Morselli PL; Thenot JP
Biomed Mass Spectrom; 1984 Jan; 11(1):29-34. PubMed ID: 6142735
[TBL] [Abstract][Full Text] [Related]
15. Determination of the beta-blocker betaxolol and labelled analogues by gas chromatography/mass spectrometry with selected ion monitoring of the alpha-cleavage fragment (m/z 72).
Lee CR; Coste AC; Allen J
Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):387-92. PubMed ID: 2907410
[TBL] [Abstract][Full Text] [Related]
16. Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS.
Buszewski B; Welerowicz T; Tegowska E; Krzemiński TF
Anal Bioanal Chem; 2009 Jan; 393(1):263-72. PubMed ID: 18781297
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids.
Reiff K
J Chromatogr; 1987 Jan; 413():355-62. PubMed ID: 2881938
[No Abstract] [Full Text] [Related]
18. Elimination of nadolol by patients with renal impairment.
Herrera J; Vukovich RA; Griffith DL
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
[TBL] [Abstract][Full Text] [Related]
19. Gas chromatographic-mass spectrometric assay for the ultra-short-acting beta-blocker esmolol.
Sum CY; Yacobi A
J Pharm Sci; 1984 Aug; 73(8):1177-9. PubMed ID: 6149299
[TBL] [Abstract][Full Text] [Related]
20. A solid phase extraction method for determination of nicotine in serum and urine by isotope dilution gas chromatography/mass spectrometry with selected ion monitoring.
Baskin LB; Anderson RW; Charlson JR; Hurt RD; Lawson GM
Ann Clin Biochem; 1998 Jul; 35 ( Pt 4)():522-7. PubMed ID: 9681054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
